Skip to main content

MustGrow Biologics sees massive growth in patent portfolio

MustGrow Biologics CEO Corey Giasson joined Steve Darling from Proactive to share news the company has seen its portfolio of patents grow exponentially.

Giasson tells Proactive its IP portfolio has grown from 23 to 84 total patents issued and pending over the last three years. In fact, 62 have been issued which is an increase from 18 issued patents three years ago.

Contact Details

Proactive Canada

+1 604-688-8158

na-editorial@proactiveinvestors.com

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.